ADS · CUSIP 07725L102 · who reports it, how much, and how much it matters to them
16 of the 720 hedge fund managers we track reported shares of BeOne Medicines Ltd. (Nasdaq: ONC) on Form 13F for 30 June 2026. Between them they reported USD 3.3bn. The largest position belongs to Baker Bros. Advisors, at USD 2.5bn.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Baker Bros. Advisors2 funds on PPLI.com | USD 2.5bn | 12.6% |
| 2 | Citadel Advisors32 funds on PPLI.com | USD 406m | 0.0% |
| 3 | Millennium Management6 funds on PPLI.com | USD 155m | 0.1% |
| 4 | Two Sigma Investments35 funds on PPLI.com | USD 82m | 0.1% |
| 5 | Marshall Wace LLP84 funds on PPLI.com | USD 51m | 0.0% |
| 6 | Artisan Partners1 fund on PPLI.com | USD 33m | 0.1% |
| 7 | Renaissance Technologies13 funds on PPLI.com | USD 29m | 0.0% |
| 8 | Squarepoint Ops7 funds on PPLI.com | USD 22m | 0.0% |
| 9 | Barings1 fund on PPLI.com | USD 12m | 0.2% |
| 10 | Engineers Gate Manager1 fund on PPLI.com | USD 4.6m | 0.1% |
| 11 | Superstring Capital Management1 fund on PPLI.com | USD 3.5m | 2.2% |
| 12 | Partners Capital Investment Group, LLP26 funds on PPLI.com | USD 1.3m | 0.0% |
| 13 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 551,000 | 0.0% |
| 14 | Walleye Capital8 funds on PPLI.com | USD 206,000 | 0.0% |
| 15 | Bayforest Capital1 fund on PPLI.com | USD 20,233 | 0.0% |
| 16 | Summit Global Investments1 fund on PPLI.com | USD 207 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Baker Bros. Advisors | USD 2.5bn | 12.6% |
| 2 | Superstring Capital Management | USD 3.5m | 2.2% |
| 3 | Barings | USD 12m | 0.2% |
| 4 | Engineers Gate Manager | USD 4.6m | 0.1% |
| 5 | Two Sigma Investments | USD 82m | 0.1% |
| 6 | Millennium Management | USD 155m | 0.1% |
| 7 | Artisan Partners | USD 33m | 0.1% |
| 8 | Citadel Advisors | USD 406m | 0.0% |
| 9 | Partners Capital Investment Group, LLP | USD 1.3m | 0.0% |
| 10 | Marshall Wace LLP | USD 51m | 0.0% |
BeOne Medicines Ltd. trades under the symbol ONC on the Nasdaq. Its CUSIP, the code used on Form 13F, is 07725L102.
16 of the 720 hedge fund managers PPLI.com tracks reported BeOne Medicines Ltd. shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 2.5bn), Citadel Advisors (USD 406m), Millennium Management (USD 155m), Two Sigma Investments (USD 82m) and Marshall Wace LLP (USD 51m).
16 managers in our coverage reported it, and between them they run 249 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Baker Bros. Advisors, where the position was 12.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BeOne Medicines Ltd. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.